eli lilly phase 3 trial retatrutide

eli lilly phase 3 trial retatrutide said Thursday its experimental obesity drug delivered up to 28.3 percent body-weight reduction over 80 weeks in the pivotal TRIUMPH-1 trial, a result nearing the weight-loss range Eli Lilly infiltrates anti-obesity market

Name: eli lilly phase 3 trial retatrutide said Thursday its experimental obesity drug delivered up to 28.3 percent body-weight reduction over 80 weeks in the pivotal TRIUMPH-1 trial, a result nearing the weight-loss range Eli Lilly infiltrates anti-obesity market
Brand: ctstranslates.com
SKU: 43087086535
Price: 21.28 USD
Availability: InStock
Rating: 4.5751 (19 reviews)

SKU: 43087086535

4.6

USD21.28 USD48.28

Pay in 4 interest-free payments of $5.32 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

Description

Yes, often, though the direction varies

doi: 10.1038/s41366-018-0303-y 135 HajnalAKovacsPAhmedTMeirellesKLynchCJCooneyRN

Research from obesity pharmacotherapy trials consistently shows that higher protein intake (targeting 0.8-1.0 grams per pound of goal body weight daily) significantly improves lean mass retention during rapid weight loss